Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 9,287 | 5,490 | 1,245 | 14,941 | 3,154 |
| Gross Profit | 9,287 | 5,490 | 1,245 | 14,941 | 3,154 |
| Operating Expenses | 50,787 | 57,639 | 54,470 | 58,653 | 48,197 |
| Operating Income | -41,500 | -52,149 | -53,225 | -43,712 | -45,043 |
| Interest Expense | 796 | 1,245 | 713 | 0 | 0 |
| Other Income | 1,622 | 2,661 | 928 | 46 | 464 |
| Pre-tax Income | -40,674 | -50,733 | -53,010 | -43,666 | -44,579 |
| Income Tax | N/A | N/A | N/A | 495 | 206 |
| Net Income Continuous | -40,674 | -50,733 | -53,010 | -44,161 | -44,785 |
| Net Income | $-40,674 | $-50,733 | $-53,010 | $-44,161 | $-44,785 |
| EPS Basic Total Ops | -0.72 | -1.11 | -1.49 | -1.41 | -1.56 |
| EPS Basic Continuous Ops | -0.72 | -1.11 | -1.49 | -1.41 | -1.56 |
| EPS Diluted Total Ops | -0.72 | -1.11 | -1.49 | -1.41 | -1.56 |
| EPS Diluted Continuous Ops | -0.72 | -1.11 | -1.49 | -1.41 | -1.56 |
| EPS Diluted Before Non-Recurring Items | -0.72 | -1.11 | -1.49 | -1.41 | -1.56 |
| EBITDA(a) | $-41,066 | $-51,790 | $-52,593 | $-42,459 | $-43,901 |